Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 117
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Nanotechnology ; 35(43)2024 Aug 05.
Article in English | MEDLINE | ID: mdl-39059416

ABSTRACT

Vanadium pentoxide (V2O5) nanoparticles exhibit diverse properties and have been studied for a wide range of applications, including energy storage, catalysis, environmental remediation, and material enhancement. In this work, we have reported the synthesis of vanadium pentaoxide (V2O5) nanoparticles using hydrothermal method. Ammonium metavanadate (NH4VO3) was used as a source of vanadium. These syntheses were carried out at four different concentrations of vanadium source. The hydrothermal reaction was conducted at a temperature of 180 °C for a duration of 24 hours, followed by an additional 24 hours period of natural cooling. Four samples were annealed in air using a muffle furnace at 500 °C for five hours. The x-ray diffraction technique was used to study the structural aspects. A comparative analysis of the microstructure was conducted utilizing the Scherrer method, the Williamson-Hall method and its various models, size-strain analysis, and the Halder-Wagner method. The crystallite size and microstrain were determined using these distinct methods, revealing a systematic correlation between the crystallite size and microstrain obtained through the different techniques.

2.
Regul Toxicol Pharmacol ; 147: 105538, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38151226

ABSTRACT

Organically synthesized fully saturated form of Anacardic acid (AA) has previously shown to be effective in the treatment of inflammatory autoimmune disease. In this study, organically synthesized fully saturated form of AA was orally administered to male and female Swiss albino mice for 90 consecutive days at doses of 25, 50 and 100 mg/kg BW (n = 20 per sex/group). Administration of AA was well tolerated at all dose levels. The treated animals did not show a dose-response toxicity in their hematology, liver, or metabolic profile. Minimally significant changes in serum biochemistry and hematology parameters were noted, but these were not considered to be of biological or toxicological importance and were not outside the known accepted ranges. Sporadic differences in organ weights were observed between groups, but all were minimal (<10%) and unlikely to indicate toxicity. The incidence of histopathological lesions was comparable between treated and control groups across all tested organs. Based upon these findings, the no-observed-adverse-effect level was determined to be ≥ 100 mg/kg BW, which was the highest dose tested. There were no genotoxic (mutagenic and clastogenic) effects seen in In-vivo micronucleus test, In-vitro chromosomal aberration test and Bacterial reverse mutation test. These results support, no genotoxicity and no toxicity associated with oral consumption of AA in mice as a dietary supplement for beverages and food.


Subject(s)
Anacardic Acids , Mutagens , Mice , Male , Female , Animals , Anacardic Acids/toxicity , No-Observed-Adverse-Effect Level , Mutation , DNA Damage
3.
Neurobiol Dis ; 116: 1-12, 2018 08.
Article in English | MEDLINE | ID: mdl-29684437

ABSTRACT

Neonatal seizures associated with hypoxic-ischemic encephalopathy (HIE) pose a challenge in their acute clinical management and are often followed by long-term neurological consequences. We used a newly characterized CD-1 mouse model of neonatal ischemic seizures associated with age-dependent (P7 vs. P10) seizure severity and phenobarbital efficacy (i.e.; PB-resistant vs. PB-efficacious respectively) following unilateral carotid ligation. The long-term consequences following untreated neonatal seizures in P7 vs. P10 ligated pups were investigated using neurobehavioral testing, 24 h v- quantitative EEG -EMG (qEEG, qEMG), and western blot analyses in adult mice. Significant hyperactivity emerged in a small sub-set of mice in both age-groups associated with a failure to habituate during open-field (OF) testing. 24 h continuous qEEGs detected significantly altered sleep architecture due to long-wake cycles in both age-groups. Delta power (0.5-4 Hz) quantification during slow-wave-sleep (SWS) revealed significant SWS compensation in P10 ligates following periods of increased sleep pressure which the P7 ligate group failed to show. Theta/beta ratios deemed as negative correlation markers of attentional control were significantly higher only in the P10 ligates. These results indicate that neonatal age-dependent differences in the characteristics of ischemic neonatal seizures in CD-1 pups differentially modulate long-term outcomes, when evaluated with v-qEEG/EMG as adults.


Subject(s)
Brain Ischemia/physiopathology , Disease Models, Animal , Electroencephalography/methods , Seizures/physiopathology , Sleep Wake Disorders/physiopathology , Age Factors , Animals , Animals, Newborn , Brain Ischemia/complications , Female , Male , Maze Learning/physiology , Mice , Seizures/complications , Sleep Wake Disorders/etiology
4.
J Postgrad Med ; 64(4): 247-249, 2018.
Article in English | MEDLINE | ID: mdl-30147083

ABSTRACT

Lipoprotein lipase (LPL) deficiency is an autosomal recessive metabolic disorder with varying presentation in infancy and childhood, whereas clinical manifestations are rare in neonatal period. The estimated prevalence is one in a million births. A 23-day-old baby was admitted with complaints of fever, vomiting, and lethargy. Blood sample drawn appeared lipemic. Lipemia retinalis was noted on funduscopic examination. Biochemical analysis revealed abnormal lipid profile with severe hypertriglyceridemia (10,300 mg/dL) and elevated serum lipase level (517 IU/L) indicative of LPL deficiency with acute pancreatitis. LPL deficiency was suspected and was confirmed by molecular genetic testing, which revealed a novel mutation in LPL gene. Dietary management and gemfibrozil were started following which serum triglyceride level decreased and serum lipase level normalized. The patient is following up regularly for growth and development monitoring.


Subject(s)
Hyperlipidemias/genetics , Lipoprotein Lipase/genetics , Pancreatitis/genetics , Humans , Hyperlipidemias/complications , Infant, Newborn , Male , Mutation
5.
Andrologia ; 50(2)2018 Mar.
Article in English | MEDLINE | ID: mdl-28776713

ABSTRACT

The aim of the study was to detect the frequency of the CFTR gene variants poly-T, TG repeats and c.1408A>G p.Met470Val (M470V) in Indian men with congenital bilateral absence of the vas deferens (CBAVD). Men diagnosed with CBAVD (n = 76), their female partners (n = 76) and healthy men from general population (n = 50) were recruited. Genomic DNA was isolated and the polymorphic regions of IVS9- c.1210-12T [5] and M470V were amplified using specific primers followed by Sanger's DNA sequencing. A statistically significant increase in the frequency of heterozygous IVS9- c.1210-12T [5] (39.4%) was observed in CBAVD men as compared to controls (14%). The allelic distribution of c.1210-12T [5], c.1210-12T [7] and c.1210-12T [9] in CBAVD men was 21%, 64.4% and 13% and that in healthy controls was 7%, 73% and 20% respectively. Longest TG repeat c.1210-34TG [13] was found in association with c.1210-12T [5] with an allelic frequency of 5.9% in CBAVD men. We found a significant association of c.1210-34TG [12]/c.1210-34TG [13] - c.1210-12[5] -V470 allele in CBAVD men. Twelve female partners harboured a heterozygous c.1210-12T [5] allele. The study emphasises the need to screen both partners for the polymorphisms M470V, poly-T, TG tract repeats in addition to population-specific known CFTR gene mutations.


Subject(s)
Asian People/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Infertility, Male/genetics , Male Urogenital Diseases/genetics , Polymorphism, Genetic , Vas Deferens/abnormalities , Alleles , Cohort Studies , Female , Genetic Carrier Screening , Genotype , Heterozygote , Humans , Male , Mutation , Sequence Analysis, DNA
6.
Regul Toxicol Pharmacol ; 90: 318-327, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28966104

ABSTRACT

The primary active constituent in bitter orange extract (BOE) is p-synephrine. This study assessed the safety of a BOE standardized to 50% p-synephrine following short-term exposure to rats and by the Ames Test. Following 5000 mg/kg of the extract orally to female rats all animals survived. Administration at 2000 mg/kg to female rats for four days yielded no signs of toxicity. Five male and five female rats were administered the BOE at 0, 250, 500, 1000 and 2000 mg/kg/day for 14 days. No significant effects were observed at any dose with respect to body weights, food intake, absolute and relative organ weights, hematology, clinical chemistry, and pathology. Two male rats died after 2000 mg/kg with gastrointestinal impaction at necropsy. During week two of 1000 mg/kg and 2000 mg/kg/day, rats exhibited transient signs of repetitive burrowing of heads in the bedding material (hypoactivity) for about 15 and 45 min, respectively. The no-observed-effect-level (NOEL) was 500 mg/kg/day. The mutagenic potential was assessed at and up to the limit dose of 5000 µg/plate in a Salmonella typhimurium reverse mutation (Ames) test, performed in duplicate as a pre-incubation assay in the presence and absence of metabolic activation (S9). The BOE did not induce an increase in the frequency of revertant colonies at any dose in the five tester strains, and was therefore non-mutagenic.


Subject(s)
Citrus/chemistry , Mutagens/toxicity , No-Observed-Adverse-Effect Level , Plant Extracts/toxicity , Synephrine/toxicity , Administration, Oral , Animals , Biological Assay/methods , Female , Gastrointestinal Tract/drug effects , Lethal Dose 50 , Male , Mutagenesis/drug effects , Mutagenicity Tests/methods , Rats , Rats, Sprague-Dawley , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Toxicity Tests, Acute
7.
BMC Genomics ; 16: 593, 2015 Aug 12.
Article in English | MEDLINE | ID: mdl-26263897

ABSTRACT

BACKGROUND: Bi-parental mapping populations have been commonly utilized to identify and characterize quantitative trait loci (QTL) controlling resistance to soybean cyst nematode (SCN, Heterodera glycines Ichinohe). Although this approach successfully mapped a large number of SCN resistance QTL, it captures only limited allelic diversity that exists in parental lines, and it also has limitations for genomic resolution. In this study, a genome-wide association study (GWAS) was performed using a diverse set of 553 soybean plant introductions (PIs) belonging to maturity groups from III to V to detect QTL/genes associated with SCN resistance to HG Type 0. RESULTS: Over 45,000 single nucleotide polymorphism (SNP) markers generated by the SoySNP50K iSelect BeadChip (http// www.soybase.org ) were utilized for analysis. GWAS identified 14 loci distributed over different chromosomes comprising 60 SNPs significantly associated with SCN resistance. Results also confirmed six QTL that were previously mapped using bi-parental populations, including the rhg1 and Rhg4 loci. GWAS identified eight novel QTL, including QTL on chromosome 10, which we have previously mapped by using a bi-parental population. In addition to the known loci for four simple traits, such as seed coat color, flower color, pubescence color, and stem growth habit, two traits, like lodging and pod shattering, having moderately complex inheritance have been confirmed with great precision by GWAS. CONCLUSIONS: The study showed that GWAS can be employed as an effective strategy for identifying complex traits in soybean and for narrowing GWAS-defined genomic regions, which facilitates positional cloning of the causal gene(s).


Subject(s)
Disease Resistance , Glycine max/genetics , Glycine max/parasitology , Plant Proteins/genetics , Animals , Chromosome Mapping , Genome-Wide Association Study , Polymorphism, Single Nucleotide , Quantitative Trait Loci , Tylenchoidea/physiology
8.
Eur J Neurosci ; 42(10): 2792-804, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26452067

ABSTRACT

Neonatal seizures are commonly associated with hypoxic-ischemic encephalopathy. Phenobarbital (PB) resistance is common and poses a serious challenge in clinical management. Using a newly characterized neonatal mouse model of ischemic seizures, this study investigated a novel strategy for rescuing PB resistance. A small-molecule TrkB antagonist, ANA12, used to selectively and transiently block post-ischemic BDNF-TrkB signaling in vivo, determined whether rescuing TrkB-mediated post-ischemic degradation of the K(+)-Cl(-) co-transporter (KCC2) rescued PB-resistant seizures. The anti-seizure efficacy of ANA12 + PB was quantified by (i) electrographic seizure burden using acute continuous video-electroencephalograms and (ii) post-treatment expression levels of KCC2 and NKCC1 using Western blot analysis in postnatal day (P)7 and P10 CD1 pups with unilateral carotid ligation. ANA12 significantly rescued PB-resistant seizures at P7 and improved PB efficacy at P10. A single dose of ANA12 + PB prevented the post-ischemic degradation of KCC2 for up to 24 h. As anticipated, ANA12 by itself had no anti-seizure properties and was unable to prevent KCC2 degradation at 24 h without follow-on PB. This indicates that unsubdued seizures can independently lead to KCC2 degradation via non-TrkB-dependent pathways. This study, for the first time as a proof-of-concept, reports the potential therapeutic value of KCC2 modulation for the management of PB-resistant seizures in neonates. Future investigations are required to establish the mechanistic link between ANA12 and the prevention of KCC2 degradation.


Subject(s)
Anticonvulsants/administration & dosage , Azepines/administration & dosage , Benzamides/administration & dosage , Brain Ischemia/complications , Brain/drug effects , Phenobarbital/administration & dosage , Receptor, trkB/antagonists & inhibitors , Seizures/prevention & control , Animals , Animals, Newborn , Brain/metabolism , Brain/physiopathology , Brain-Derived Neurotrophic Factor/metabolism , Disease Models, Animal , Electroencephalography , Female , Male , Mice , Receptor, trkB/metabolism , Seizures/etiology , Seizures/metabolism , Solute Carrier Family 12, Member 2/metabolism , Symporters/metabolism , K Cl- Cotransporters
9.
J Wound Care ; 23(9): 431-2, 434, 436 passim, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25284295

ABSTRACT

OBJECTIVE: Silver nanoparticles (AgNPs) are known for their antimicrobial profile and wound healing activities. However, cytotoxicity and cosmetic abnormalities associated with silver pose a major challenge in their translation for therapeutic applications. Our objective was to develop biogenic AgNPs, using a single-step green synthesis, and to investigate their in vitro and in vivo behaviour as wound-healing agents. METHOD: AgNPs were prepared using the green synthesis approach with aqueous Bryonia laciniosa leaves extract. The AgNPs were then evaluated for physicochemical properties, stability, and antimicrobial and in vivo wound healing activities. RESULTS: Stable AgNPs with characteristic absorption at 408nm and 15±3nm particle size were generated via the active involvement of Bryonia laciniosa. No loss of stability was detected after 6 months at room temperature. Antibacterial activity was observed against both Gram-negative and Gram-positive bacteria with no cytotoxicity observed in vitro at a concentration of 200 µg/mL and effective cytokine modulation. In vivo wound healing experiments showed improved wound contracting ability in rats where, after 14 days, wound alleviation was 47.1±2.2% in the control groups, compared with 78.1±1.4% and 92.6±6.7% for a silver-based marketed cream and the AgNPs, respectively. CONCLUSION: The developed AgNPs proved to be superior wound healing agents owing to scarless healing with insignificant inflammation and toxicity. DECLARATION OF INTEREST: There were no external sources of funding for this study. The authors have no conflicts of interest to declare.


Subject(s)
Metal Nanoparticles/therapeutic use , Silver/administration & dosage , Wound Healing , Animals , Bryonia , Enzyme-Linked Immunosorbent Assay , Metal Nanoparticles/chemistry , Plant Extracts , Rats
10.
J Prev Med Hyg ; 55(2): 65-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25916023

ABSTRACT

OBJECTIVE: To study the knowledge and practice of hand washing among mothers and children of shikharchandi slum of Bhubaneswar, Odisha and to recommend possible measures to improve the current practices. METHODOLOGY: Present cross-sectional study was carried out in the Shikharchandi slum located in the Bhubaneswar city of Orissa state in India. 150 women and 80 children were interviewed. Children questionnaire were prepared to suit to their age and according to local context. Components of sanitation like food handling and hand washing were covered in this questionnaire. RESULTS: Hand washing before preparing food is being practiced by 85% of women. Of all women interviewed, 77% wash hands before serving food. Only 15% children said soap was available in their school to wash hands. Out of total children interviewed, 76% told that their teachers tell about sanitation and hand washing in the class. Only 5% children told they were consulted by doctor/health worker during last 3 months. As many as 81% children told that they wash their hands before taking food and 19% children said they take their food without washing hands. Though most of the children told that they wash hands before taking food, but only 17.5% told that they use soap for hand washing. Only 29% children told that their teachers check hand washing in school. When asked about critical timing of hand washing, 44% children told about at least two critical timings and 56% were unaware about the critical timings of hand washing. CONCLUSION: Inadequate knowledge on this among our study participant is a point of concern. Systematic integration of health and hygiene education in schools through curricular modifications could be an appropriate strategy.


Subject(s)
Hand Hygiene/statistics & numerical data , Health Knowledge, Attitudes, Practice , Mothers/statistics & numerical data , Poverty Areas , Adolescent , Adult , Caregivers/statistics & numerical data , Child , Cross-Sectional Studies , Female , Food Handling , Hand Disinfection , Humans , India , Middle Aged , Schools/statistics & numerical data , Soaps/supply & distribution , Young Adult
11.
Hum Reprod ; 27(2): 408-17, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22158085

ABSTRACT

BACKGROUND: Non-invasive diagnosis of endometriosis is urgently required to prevent the long delay between the onset of symptoms and diagnosis. A biomarker that possesses both high sensitivity and specificity is greatly required. Here, we describe the use of a proteomic approach to identify potential novel endometrial antigens using sera from endometriosis patients and healthy controls, with evaluation of biomarkers for non-invasive diagnosis of endometriosis. METHODS: A cross-sectional study was conducted to identify specific endometrial antigens using 1D and 2D western blots in women with early endometriosis (n = 17), advanced endometriosis (n = 23) and without endometriosis (n = 30). Five immunoreactive spots were analyzed using matrix-assisted laser desorption/ionization-time-of-flight/mass spectrometry with MASCOT analysis. ELISAs were established for specific epitopes and autoantibody titres were estimated in an independent cohort comprising women with early endometriosis (n = 18), advanced endometriosis (n = 32) and without endometriosis (n = 27) for validation. RESULTS: The 2D western blot analysis resulted in the identification of three endometrial antigens, tropomyosin 3 (TPM3), stomatin-like protein 2 (SLP2) and tropomodulin 3 (TMOD3). Serum levels of antibodies against the epitopes from the immunodominant region of proteins TPM3, SLP2 and TMOD3 were significantly elevated in endometriosis patients when compared with controls. Sensitivity and specificity of serum anti-TPM3a-autoAb (61%, 93%), anti-TPM3c-autoAb (44%, 93%), anti-TPM3d-autoAb (78%, 89%), anti-SLP2a-autoAb (50%, 96%), anti-SLP2c-autoAb (61%, 93%), anti-TMOD3b-autoAb (61%, 96%), serum anti-TMOD3c-autoAb (78%, 93%) and anti-TMOD3d-autoAb (78%, 96%) were better than those of serum CA125 levels (21%, 89%) in the detection of early stages of endometriosis. CONCLUSIONS: Serum anti-TPM3a-autoAb, anti-TPM3c-autoAb, anti-TPM3d-autoAb, anti-SLP2a-autoAb, anti-SLP2c-autoAb, anti-TMOD3b-autoAb, anti-TMOD3c-autoAb and anti-TMOD3d-autoAb could be new markers for the early diagnosis of endometriosis.


Subject(s)
Endometriosis/blood , Endometriosis/diagnosis , Membrane Proteins/blood , Tropomodulin/blood , Tropomyosin/blood , Adult , Antibody Specificity , Autoantibodies/analysis , Autoantigens/blood , Autoantigens/chemistry , Biomarkers/blood , Biomarkers/chemistry , Blood Proteins/chemistry , Cohort Studies , Cross-Sectional Studies , Early Diagnosis , Endometriosis/physiopathology , Female , Humans , Immunodominant Epitopes/analysis , Immunodominant Epitopes/chemistry , Membrane Proteins/chemistry , Peptide Fragments/analysis , Peptide Fragments/chemistry , Peptide Mapping , Sensitivity and Specificity , Severity of Illness Index , Tropomodulin/chemistry , Tropomyosin/chemistry , Young Adult
12.
J Neonatal Perinatal Med ; 14(2): 229-235, 2021.
Article in English | MEDLINE | ID: mdl-33104045

ABSTRACT

BACKGROUND: Umbilical venous catheters (UVC) and peripherally inserted central catheters (PICC) are commonly used in preterms. UVC is cheap, easy to insert but has shorter dwell time. UVC is replaced after 7 days due to the risk of complications. This is associated with increased cost, work, and risk of nosocomial infections. The aim of this study was to determine the antenatal and postnatal factors that predict the need for a central line for more than 7 days, thus helping select between UVC or PICC on day 1 of life in babies ≤1500 grams. METHODS: We retrospectively collected antenatal and postnatal data of VLBW neonates over a period of 1 year who needed CL during their NICU stay. We then divided them into two cohorts. Group 1: CL ≤7 days. Group 2: CL > 7 days. RESULTS: Sepsis and catheter complications were lower with use of a single CL or duration being ≤7 days. Birth weight, incomplete/no antenatal steroids, need for resuscitation, low Apgar's, RDS, hs-PDA, and initiation of feeds beyond 24 hours of birth were significant. The score was devised based on factors found significant that had an acceptable AUC of 0.767 on ROC analysis with a score of 1 or above having 74.8% sensitivity and 67.7% specificity for prediction of need for CL > 7 days. CONCLUSIONS: Birth weight ≤1000 grams, incomplete steroids and need for resuscitation at birth were predictive of the need of CL beyond seven days, on day one of life.


Subject(s)
Catheterization, Central Venous/statistics & numerical data , Catheterization, Peripheral/statistics & numerical data , Infant, Very Low Birth Weight , Intensive Care Units, Neonatal , Catheter-Related Infections/prevention & control , Female , Humans , Infant, Newborn , Male , Umbilical Veins
13.
Epilepsy Behav ; 18(4): 344-57, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20708575

ABSTRACT

Stroke in the developing brain is an important cause of chronic neurological morbidities including neurobehavioral dysfunction and epilepsy. Here, we describe a mouse model of neonatal stroke resulting from unilateral carotid ligation that results in acute seizures, long-term hyperactivity, spontaneous lateralized circling behavior, impaired cognitive function, and epilepsy. Exploration-dependent induction of the immediate early gene Arc (activity-regulated cytoskeleton associated protein) in hippocampal neurons was examined in the general population of neurons versus neurons that were generated approximately 1 week after the ischemic insult and labeled with bromodeoxyuridine. Although Arc was inducible in a network-specific manner after severe neonatal stroke, it was impaired, not only in the ipsilateral injured but also in the contralateral uninjured hippocampi when examined 6 months after the neonatal stroke. Severity of both the stroke injury and the acquired poststroke epilepsy negatively correlated with Arc induction and new neuron integration into functional circuits in the injured hippocampi.


Subject(s)
Epilepsy/etiology , Hippocampus/pathology , Neurogenesis/physiology , Neurons/physiology , Stroke/pathology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Bromodeoxyuridine/metabolism , Cell Differentiation , Cytoskeletal Proteins/metabolism , Disease Models, Animal , Exploratory Behavior/physiology , Functional Laterality , Hippocampus/physiopathology , Maze Learning/physiology , Mice , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neurons/pathology , Stroke/complications , Time Factors , Video Recording/methods
14.
Epilepsy Res ; 159: 106249, 2020 01.
Article in English | MEDLINE | ID: mdl-31864171

ABSTRACT

A recently characterized CD-1 mouse model of phenobarbital (PB)-resistant neonatal ischemic-seizures (i.e.; unilateral carotid ligation) was shown to be associated with age-dependent (P7 vs. P10) acute seizure severity and PB-efficacy (i.e.; PB-resistant vs. PB-responsive). ANA12, a novel small-molecule TrkB antagonist, rescued the PB-resistance at P7 in a dose-dependent manner and prevented the post-ischemic downregulation of KCC2, the chief Cl- extruder in neurons. The long-term consequences of this novel rescue-intervention with ANA12 + PB in P7 and P10 ligated pups was investigated and compared to the standard first-line protocol of PB-alone loading dose. The mice underwent neurobehavioral testing, 24 h video-EEG-EMG monitoring, and immunohistochemistry in ipsi- and contralateral cortices as adults following the neonatal interventions. ANA12 + PB rescued the emergence of hyperactivity in post-ischemic P7, but not in P10 pups as adults. ANA12 + PB administration at neither P7 nor P10 significantly altered 24 h macro-sleep architecture in adults when compared to PB-alone. Behavioral state-dependent gamma (35-50 Hz) power homeostasis showed the most significant between-group differences that were age-dependent. ANA12 + PB treatment, but not PB-alone, rescued the loss of gamma power homeostasis present in P7 ligate-control but absent in P10 ligate group, highlighting the age-dependence. In contrast, PB-alone treatment, but not ANA12+PB, significantly reduced the elevated delta-AUC observed in P10 ligate-controls, when PB is efficacious by itself. These results indicate that the rescue of acute PB-resistant neonatal seizures using a novel intervention positively modulates the long-term outcomes at P7 when the seizures are refractory.


Subject(s)
Anticonvulsants/therapeutic use , Azepines/therapeutic use , Benzamides/therapeutic use , Phenobarbital/therapeutic use , Receptor, trkB/antagonists & inhibitors , Seizures/drug therapy , Animals , Azepines/pharmacology , Benzamides/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Electroencephalography , Electromyography , Mice , Spatial Memory/drug effects
15.
J Family Med Prim Care ; 9(4): 2016-2021, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32670958

ABSTRACT

AIM: To assess the awareness of various occupational hazards experienced and the preventive measures undertaken by the dentists in and around Mumbai. METHODS: The present study was conducted using self-administered questionnaire, which was circulated to 200 dentists practicing in and around Mumbai. The questionnaire also included questions on personal information like age, gender, position (student or faculty), years of experience, and number of working hours per day. Those who completed the questionnaire form completely and willing to participate were only included in the study. The results were analyzed using SPSS version 22.0. RESULTS: 23.5% of the participants had the dental working experience more than 10 years and 28.5% dentists worked for ≥8 h. 69% were general practitioners and 40% of the participants treat nearly 10 to 20 patients per day. 45% of them experienced needle stick injury in clinical practice. 1.5% of dentists in our study admitted receiving some litigation from their patients. CONCLUSION: The present study indicated that occupational hazards, awareness about biological hazards, and preventive measures observed by dentists in Mumbai are generally consistent with published guidelines for infection control and also in accordance with the previous research. The majority of the dental practitioners were suffering from pain in the muscles of neck or back. Regular training and workshops can help lower such problems.

16.
J Neurosci Res ; 87(12): 2653-66, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19396874

ABSTRACT

Stroke in the neonatal brain is an understudied cause of neurologic morbidity. Recently we have characterized a new immature mouse model of stroke utilizing unilateral carotid ligation alone to produce infarcts and acute seizures in postnatal day 12 (P12) CD-1 mice. In this study, the amount of poststroke neural progenitor proliferation was examined in the subgranular (SGZ) of the dentate gyrus and the subventricular zone (SVZ) 7, 14, and 21days after ischemia (DAI). A single IP injection (50 mg/kg) of bromodeoxyuridine (BrdU) given 2 hr before perfusion fixation labeled newborn cells. Early cell phenotypes were quantified by colabeling with GFAP, nestin, and DCX. Control mice revealed an age-dependent decrease in neural proliferation, with an approximately 50% drop in BrdU-labeled cell counts at P33 compared with P19 both in the SGZ and in the SVZ. Significant reduction in the amount of neural proliferation in the ipsilateral injured SGZ of ligated mice correlated with both the severity of the stroke-injury and the acute seizure scores. Similar correlations were not detected contralaterally. Contralateral SGZ neural proliferation was initially lowered at 7 DAI but normalized by 21 DAI. In both injured and control brains, approximately 90% of newborn SGZ cells colabeled with nestin, approximately 30% colabeled with GFAP, and a few colabeled with DCX. In contrast, poststroke SVZ cell proliferation was enhanced ipsi- more than contralaterally at 7 DAI. In the SVZ, the enhanced neural proliferation normalized to control levels by P33. In conclusion, the neural cell proliferation was differentially altered in the SGZ vs. SVZ after neonatal stroke.


Subject(s)
Cell Proliferation , Neuronal Plasticity/physiology , Regeneration/physiology , Stem Cells/metabolism , Stroke/physiopathology , Telencephalon/growth & development , Age Factors , Animals , Animals, Newborn , Biomarkers/metabolism , Brain Ischemia/physiopathology , Bromodeoxyuridine , Disease Models, Animal , Doublecortin Domain Proteins , Doublecortin Protein , Female , Glial Fibrillary Acidic Protein/metabolism , Intermediate Filament Proteins/metabolism , Male , Mice , Microtubule-Associated Proteins/metabolism , Nerve Tissue Proteins/metabolism , Nestin , Neuroglia/cytology , Neuroglia/metabolism , Neurons/cytology , Neurons/metabolism , Neuropeptides/metabolism , Stem Cells/cytology , Telencephalon/cytology
17.
J Neonatal Perinatal Med ; 12(2): 127-134, 2019.
Article in English | MEDLINE | ID: mdl-30741696

ABSTRACT

BACKGROUND: Perinatal asphyxia is a prominent cause of neonatal mortality in the developing world. Growth in head circumference is associated with improved neurodevelopment. Previous studies found a positive correlation between additional dietary supplementation and growth in head circumference among newborns with perinatal brain injury. This study aims to evaluate the association between anthropometric parameters and developmental outcomes in newborns with hypoxic ischemic encephalopathy (HIE). METHODS: Newborns at ≥36 weeks gestation with moderate to severe HIE were included in the study and growth parameters were monitored. Newborns with life-threatening anomalies were excluded. None of the study participants received therapeutic hypothermia (TH). Developmental Assessment Scale for Indian Infants (DASII) was used to evaluate neurodevelopmental outcomes at 1 year of age. RESULTS: Of 76 study participants, 46 were followed for 12 months, 28 died, and 2 were lost to follow-up. HIE stage III, Apgar score <5 at 5 minutes of age, pH ≤ 7.1 on first blood gas and base deficit > - 16 was associated with death or disability at 1 year of age. All anthropometric parameters were significantly lower in presence of death or disability. pH ≤ 7.1 at birth (odds ratio: 11.835, 95% CI 2.273-61.629, p = 0.003) and weight gain at one year (odds ratio 1.001, 95% CI 1.000-1.002, p = 0.03) were significantly associated with death and disability. CONCLUSION: pH > 7.1 at birth, and weight gain were associated with better neurodevelopmental outcomes at 1 year of age. Thus, in addition to TH, nutritional interventions may potentially improve outcomes among newborns with HIE.


Subject(s)
Asphyxia Neonatorum/physiopathology , Body Weight , Cephalometry , Child Development , Head/growth & development , Hypoxia-Ischemia, Brain/physiopathology , Weight Gain , Anthropometry , Anticonvulsants/therapeutic use , Asphyxia Neonatorum/complications , Blood Gas Analysis , Cerebral Palsy/epidemiology , Female , Humans , Hydrogen-Ion Concentration , Hypoxia-Ischemia, Brain/complications , India , Infant , Infant, Newborn , Male , Microcephaly/epidemiology , Outcome Assessment, Health Care , Seizures/drug therapy , Seizures/epidemiology , Severity of Illness Index
18.
Nanoscale Adv ; 1(1): 403-413, 2019 Jan 15.
Article in English | MEDLINE | ID: mdl-36132473

ABSTRACT

Nanocrystalline Ce-substituted yttrium iron garnet (YIG) powders of different compositions, Y3-x Ce x Fe5O12 (0 ≤ x ≤ 2.0), were synthesized by a combination of sol-gel auto-combustion and solid-state synthesis techniques. The as-obtained powder samples were sintered at 1150 °C for 10 h. The garnet structure formation is confirmed by the X-ray diffraction pattern, which shows that the calculated lattice parameter increased for x = 1.0 and shows a decreasing trend for x ≥ 1.0 with the addition of cerium ions. The lattice parameter increased from 12.38 Å to 12.41 Å for x ≤ 1.0 whereas it decreased from 12.412 Å to 12.405 Å with the cerium composition for x > 1.0. The average particle size determined by high resolution transmission electron microscopy is in the range of 50 to 90 nm and found to increase with the substitution of cerium ions in YIG. The room temperature magnetic parameters such as saturation magnetization, coercivity and remanence magnetization are greatly affected by the substitution of cerium ions. The values of saturation magnetization decrease from 25.5 to 15 emu g-1 whereas coercivity increases from 1 to 28 Oe with the substitution of cerium ions. The pure YIG sample shows polycrystalline nature that changed towards a single-crystal structure leading to a preferred-(100) orientation with the Ce substitution. The change from a ring to a spotty pattern observed in SAED confirmed the crystalline phase transformation and is well supported by HRTEM and magnetic measurements. The behavior of magnetic and electrical properties is well supported by the poly- and single-crystalline nature of YIG and Ce-YIG, respectively. The crystal structure transformation in YIG brought about by Ce substitution could unveil enormous opportunities in the preparation of single-crystal materials from their polycrystalline counterparts.

19.
Brain Res ; 1208: 35-45, 2008 May 07.
Article in English | MEDLINE | ID: mdl-18387598

ABSTRACT

Stroke in the neonatal brain is an important cause of neurologic morbidity. To characterize the dynamics of neural progenitor cell proliferation and maturation after survival delays in the neonatal brain following ischemia, we utilized unilateral carotid ligation alone to produce infarcts in postnatal day 12 CD1 mice. We investigated the neurogenesis derived from the sub-ventricular zone and the sub-granular zone of the dentate gyrus subsequent to injury. Newly produced cells were labeled by bromodeoxyuridine at approximately 1 week (P18-20) after the insult by 5 i.p. injections (each 50 mg/kg). Subsequent migration and differentiation of the newborn cells was investigated at postnatal day 40 by immunohistochemistry for molecular neuronal and glial cell-lineage markers and BrdU incorporation. Cresyl violet stain demonstrated massive loss of neurons in the ipsilateral septal hippocampus in the CA3 and CA1 regions associated with atrophy. Total counts of new cells were significantly lowered not only in the ipsilateral injured but also the contralateral uninjured hippocampi and correlated with the lesion induced atrophy. Bilateral percent neuronal commitments in the dentate gyri however, were not significantly different from control. New cell densities in the neocortex and striatum increased bilaterally after neonatal stroke. The predominantly non-neuronal commitment of the SVZ-derived new cells was similar to the percentage of non-neuronal commitment in controls. In conclusion, neurogenesis occurring at 1 week after neonatal ischemia in the model maintained cell-lineage commitment patterns similar to sham controls. However, the total number of hippocampal SGZ-derived new neurons was reduced bilaterally; in contrast, the SVZ-derived neurogenesis was amplified.


Subject(s)
Brain/pathology , Cell Proliferation , Hypoxia-Ischemia, Brain/pathology , Neurons/physiology , Animals , Animals, Newborn , Antigens/metabolism , Bromodeoxyuridine/metabolism , Cell Count , Cell Differentiation , Disease Models, Animal , Functional Laterality , Glial Fibrillary Acidic Protein/metabolism , Mice , Phosphopyruvate Hydratase/metabolism , Proteoglycans/metabolism
20.
Sci Rep ; 8(1): 11987, 2018 08 10.
Article in English | MEDLINE | ID: mdl-30097625

ABSTRACT

Neonatal seizures have an incidence of 3.5 per 1000 newborns; while hypoxic-ischemic encephalopathy (HIE) accounts for 50-60% of cases, half are resistant to 1st-line anti-seizure drugs such as phenobarbital (PB). Tyrosine receptor kinase B (TrkB) activation following ischemic injury is known to increase neuronal excitability by downregulation of K-Cl co-transporter 2 (KCC2); a neuronal chloride (Cl-) co-transporter. In this study, three graded doses of ANA12, a small-molecule selective TrkB antagonist, were tested in CD1 mice at P7 and P10 following induction of neonatal ischemia by a unilateral carotid ligation. The PB loading dose remained the same in all treatment groups at both ages. Evaluation criteria for the anti-seizure efficacy of ANA12 were: (1) quantitative electroencephalographic (EEG) seizure burden and power, (2) rescue of post-ischemic KCC2 and pKCC2-S940 downregulation and (3) reversal of TrkB pathway activation following ischemia. ANA12 significantly rescued PB resistant seizures in a dose-dependent manner at P7 and improved PB efficacy at P10. Additionally, female pups responded better to lower doses of ANA12 compared to males. ANA12 significantly reversed post-ischemic KCC2 downregulation and TrkB pathway activation at P7 when PB alone was inefficacious. Rescuing KCC2 hypofunction may be critical for preventing emergence of refractory seizures.


Subject(s)
Drug Resistance , Phenobarbital/pharmacology , Seizures/metabolism , Symporters/metabolism , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Electroencephalography , Female , Gene Expression Regulation/drug effects , Humans , Infant, Newborn , Male , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/metabolism , Phenobarbital/administration & dosage , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Seizures/diagnosis , Seizures/drug therapy , Seizures/etiology , Symporters/genetics , K Cl- Cotransporters
SELECTION OF CITATIONS
SEARCH DETAIL